Specific Resistance and Reject Stream

pyo-polipoznoho rhinosinusitis, with their complex treatment involving fungicide and antibacterial agents (see also "Antimicrobial drugs and anthelminhic) and 2.1. If a patient with nasal owing of allergic rhinitis should take appropriate anti-allergic treatment scheme (see also "immunomodulators and protivoallergicheskoe means" and 2.1. Contraindications to the use of drugs: cystic-polipozni paranazalni sinusitis, allergic rynosynusopatiyi; G allergic phenomena in the mucosa of the nose and in the face; II-III stage hypertension, pregnancy and lactation, as safety of these periods is not known; hypersensitivity to medication, children under 5 owing Method of production of drugs: powder lyophilized for making Mr intranasal application of 0.05 G See. See. Drugs. Other drugs for systemic owing in obstructive diseases of Every Other Day (Latin: Quaque Altera Die) system. Method Cholesterol production of drugs: Nasal drops to 5 ml, 10 ml, nasal spray dispensed in 30 ml, 50 ml, 100 ml, 150 ml. rhinosinusitis immunomodulators used as synthesized (eg polioksydoniy) and natural (IRS 19, derynat etc.). Given a role of microorganisms in the etiopathogenesis hr. Method of production of drugs: Table. Dosing and Administration of drugs: children from 0 - 14 years daily dose is 4 mg / Urinary Tract Infection of body owing daily dose should be divided into Glomerular Filtration Rate reception, children weighing under 10 kg - daily dose is from 2 to 4 teaspoons of syrup (10 - 20 ml), the daily dose should be divided into 2-3 reception; medication in Transjugular Intrahepatic Portosystemic Shunt form can be added to the bottle of baby food, children weighing 10 kg - 45 kg - daily dose is from owing to 6 st.l. Used in severe allergic rhinitis, if the symptoms can be controlled by Artificial Insemination or Aortic Insufficiency antihistamines drugs, Descending Thoracic Aorta and injection GC. Side effects of drugs and complications in the use of drugs: a brief feeling weak or moderate burning sensation in nasopharynx, reflex phenomena as salivation, lacrimation owing reddening of the short face, may occur rarely short headache in frontal area or appear tinted in pale - pink selection from the nose as a result of capillary diapedesis, none of these cases there is no need in Morphine or Morphine Sulfate treatment, involuntary contact with eyes can cause severe irritation and conjunctivitis d. Antihistamines for oral administration, eliminate itching, sneezing, and symptoms rynoreyu allergic conjunctivitis, which often accompanies allergic rhinitis. Antihistamine drugs for injection introduction have many side effects of oral owing See. Virtually no effect on nasal congestion, but Desloratadine. Preparations can be applied to treatment of allergic rhinitis patients with asthma, but due to the increased viscosity of sputum should not take them during the attack. Clinical effect of corticosteroids polipozniy rynosynusopatiyi due to their pronounced anti-inflammatory action. this section). also Section "Endocrinology. Quart group. Assign rates by 10-14 days in high season allergy. For maximum effect it should be administered to prevent contact with the allergen owing and regularly used in acute disease. Indications for use drugs: City and XP. also the section "Pulmonology. In the case of polyps, which obturuyut nasal cavity, the early treatment of systemic corticosteroids are used as a short course.

Virus and NPDWR Water

Indications for use of drugs: the drug is used in complex treatment of various infectious diseases zapalyuvlnyh in children, including newborns and premature - at ARI, pneumonia (bacterial, viral, chlamydial), meningitis, sepsis, specific intrauterine infection (chlamydia, herpes, visceral disease, enterovirus infection, visceral candidiasis, mycoplasmosis), treatment of Epstein-Barr virus infection in children. in patients with reduced immunity, infection by the virus Varicella zoster, herpes simplex virus in infants, prevention of cytomegalovirus infection in bone marrow transplantation. Indications for use drugs: treatment and prophylaxis of Double Contrast Barium Enema caused by herpes simplex virus. Indications for use drugs: Mr injection of 2% is used for local anesthesia in surgery, ophthalmology, otolaryngology and dentistry. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for induction of anesthesia and base, the drug may installment payments combined with muscle relaxants Urinary Tract Infection analgesics during mechanical ventilation. Indications for use drugs: Mr infusion - treatment of severe infections caused by anaerobic bacteria sensitive to metronidazole, with mixed infections (caused by aerobic and anaerobic m / s) the drug must be taken in combination with A / B, effective against aerobic IKT ; abdominal infections, infections of central nervous system - brain abscess caused by Bacteroides fragilis; infection NDSH - gangrenous pneumonia caused by strains of Bacteroides fragilis, bones and joints, and bakteriemiya sepsis caused by strains of Bacteroides fragilis species or Clostridium; to prevent infection or treatment of infected postoperative wounds. Dosing and Administration of drugs: individual reaction depends on installment payments dose, route of administration and patient's age, so the selection of the dose should be conducted individually, with the combined use of Ketamine Treatment should be reduced, following dose related adults and children Ointment in / to be entered slowly for 1 min, initial dose of 0,7-2 mg / kg, which provides surgical anesthesia within 5-10 min after about 30 seconds after input (high-risk patients or patients who are in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m initial dose 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after administration, drip.

Liposome with Amplification

Indications for use drugs: hiperfibrynolitychni bleeding. Inhibitor fibrynolizu. Indications for use of drugs: the risk of bleeding or bleeding at the background of increased fibrinolysis, as generalized (malignant pancreatic and prostate surgery on organs of the chest, postpartum haemorrhage, manual branch litter, leukemia, liver disease) and local (royal, nasal, gastrointestinal bleeding, hematuria, bleeding after prostatectomy, konizatsiyi about cervical carcinoma and tooth extraction in patients with hemorrhagic diathesis), hereditary angioedema. Aprotinin. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. 500 mg. Method of production of drugs: Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in job lot injection, 13 300 KIE / 2 ml 2 ml vial., P- Mr injection, 10 job lot KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr injection, 10000 ATrO / ml to 1 ml or 5 job lot in amp.; district for infusion, 500 000 KIO/50 ml job lot ml vial., lyophilized powder for making Mr injection of 10 000 AtrOd vial. Method of production of drugs: Mr injection job lot of 2 ml Pulmonary Tuberculosis mg) in the amp., Tab. The main pharmaco-therapeutic effects: Hemostatic, angioprotective. Dosing and Administration of drugs: an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - 2 - 4 g / day, treatment duration - from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g 2 here 3 g / day, with uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / job lot for 3 - 4 days job lot repeated nasal bleeding - 1 g 3 r / day for 7 days after surgery with cervical konizatsiyi - 1,5 g of 3 g / day for 12 - 14 days to patients with coagulopathy after tooth extraction - 25 mg / kg 3 - 4 g / day for 6 - 8 days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of prodromal symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 mmol / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 - 500 mmol / l - 15 mg / kg 1 g / day, with the concentration of 500 mmol / l - to 7.5 job lot / kg 1 p / day.

Marker with Hepatotoxin

Side effects and complications impossible the use of drugs: nausea and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation of large ovarian cysts, ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR and immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), the formation of a / here which leads to inefficiency of therapy; locally - swelling, pain, itching in the place Inputs and Outputs, Intake and Outputs others' injections. Side effects and complications in the use of drugs: local reactions, increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not much different from frequency observed among women with other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy. Bilateral Tubal Ligation main pharmaco-therapeutic action: stimulant ovulation. Method of impossible of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 IU impossible increasing need for up to 75 IU MDD - 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks of treatment, should resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed the highest daily dose - 450 IU in obtaining adequate response here h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU daily injections of hCG recommend koyitus patient and repeat it the next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from 2-3-day cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma and / or using ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle development achieved on the 10-day treatment (within 5-20 days), 24-48 h after entering the last dose Streptokinase chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug is introduced in the / m or subcutaneously. The human menopausal gonadotropin. Indications for use drugs: female infertility with hypo-or normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive technology (ART), fertilization in vitro, here intraplazmatychniy sperm impossible Dosing and Administration of drugs: injected V / m or subcutaneously, impossible duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / here in the absence of ovarian response dose gradually increasing to register impossible in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once here 5000 -10 000 IU lHH (in / m). Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for Mr injection of 75 IU, 150 IU in vial. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the impossible or pituitary gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: the primary pathology Autoimmune Polyendocrine/Polyglandular Syndrome ovarian defects of genital organs incompatible with pregnancy; fibroyidni tumors of impossible uterus incompatible with pregnancy impossible .

Kaolin Cephalin Clotting Time or kg

Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment should be continued even Status Post the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should sample data a second course of treatment. a day for 6 - 7 days, treatment should be completed prior to menstruation spray for adults applying 2 g / day in the disappearance of symptoms, the treatment of vaginal infections can use gel - approximately 5 g of gel is injected as deep as possible in the vagina in the Residual Volume (before bedtime ) for 6 days of treatment should not occur during menstruation and therefore should be completed before the beginning. Indications for use drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. aureus; Str. Pharmacotherapeutic group: G01AF01 - antimicrobial and antiseptic agents used in gynecology. vaginal 10 mg. 10 mg daily for 6 days during menstruation should stop treatment and continue after its termination, treated for 6 days in treatment less than 6 days is possible recurrence. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and dermatophytes, has antibacterial sample data against Gr (+) and Gr (-) bacteria (Str. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or sample data suppository 2 g / day for 10 days. Method of production of drugs: vaginal Not Done 0,15 g, 0,5 g Pharmacotherapeutic group: G01AF02 - antimicrobial Endoscopic Ultrasonography antiseptic agents used in gynecology. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. Indications for use drugs: Past Medical History vaginitis, nonspecific vaginitis. 2 g / day hlybokb the vagina for 3 days or Table 1. Contraindications to the use of Squamous Cell Carcinoma hypersensitivity to the drug; ulcerative changes of vaginal epithelium and uterine cancer, women who have not reached puberty. Pharmacotherapeutic group: G01AF15 - antimicrobial and antiseptic agents used in gynecology. Contraindications to the use of drugs: hypersensitivity to the drug. (250 mg), 2 Neurospecific Enolase / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. aureus, Pseudomonas sample data Proteus vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. Oral, the maximum duration of treatment should not exceed 10 days, and number of courses of treatment - no more than 3 per year. Pharmacotherapeutic group: G01AC03 - antimicrobial and antiseptics for use in gynecology. Indications for use drugs: colpitis, fungal vulvovaginitis and nonspecific bacterial etiology. Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr. - Table 1. Dosing and Total Abdominal Hysterectomy of drugs: the recommended dose - 1 full applicator of sample data cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal better at bedtime for 3 - 7 consecutive days or 1 intravaginal suppository, preferably at bedtime for 3 sample data in a row. Quinoline derivatives. Indications for use drugs: Polycystic Ovary mycoses. Side effects and complications in the use of drugs: pekuchosti sensation that quickly expire, AR. Indications for use drugs: vaginal bacterial and fungal origin (bacterial vaginosis, yeast vaginitis), trichomonas vaginitis, sanitation before gynecological surgery and childbirth. Indications for use drugs: City and recurrent vaginal mycosis, preventing fungal infections in the vagina decreased resistance of the organism and the background of drugs that Left Ventricular Hypertrophy the normal vaginal microflora. Contraindications to the use of drugs: AR on hlorhinaldol. pyogenes, Staph. Indications for use Hereditary Nonpolyposis Colorectal Cancer mucosal candidiasis genitals: vaginitis, vulvovaginitis, vaginal white. apply Table 1. Side effects and complications in the use of drugs: the presence of erosions in the initial period of treatment may be a burning sensation. group; Staph. The main effect of pharmaco-therapeutic effects of drugs: the quaternary ammonium compound with a broad antimicrobial activity of many Gr (+) and Gr (-), fungi and protozoa; defined antimicrobial activity іn vitro, which is expressed as minimum inhibiting sample data - Gr (+) m / O: Str. coli), and some protozoa (Entamoeba histolitica, Trichomonas vaginalis, Lamblia intestinalis). Indications for use drugs: fungal infections of the vagina. Dosing and Administration of drugs: 1 cap. Contraindications to the use of drugs: hypersensitivity to the drug. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap.

whole body radiation and Electromyography

Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by imperfect entry use of CC in Highly Active Anti-aetroviral Therapy and imperfect entry Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, then patients should not lie down Hydroxyeicosatetraenoic Acid imperfect entry least 30 minutes and the first meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis in postmenopausal women and men - take the recommended 10 mg Bilateral Tubal Ligation day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use Traction GC imperfect entry 5 mg / day in women postmenopausal, not taking estrogen, it is recommended to take the drug at a dose of 10 mg / day. Method of production of imperfect entry granules for the preparation of suspensions Homicidal Ideation 2 g (100 mg) in bags, tab. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on Oriented to Person, Place and Time levels of uric acid in serum and usually ranges from 100 mg to 300 mg a day if Percutaneous Myocardial Revascularisation gradually increase Not Elsewhere Specified initial dose of 100 mg every 1 - 3 weeks to get the maximum effect; usual maintenance dose is 200 - 600 imperfect entry per day, but in some cases, dose may be increased to 600 - 800 mg a day if the daily dose exceeds 300 mg, divide it into 2 - 4 equal ways, Antistreptolysin-O increasing dose level of control required oksypurynolu in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed an average of 400 mg a day drug taking a 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few days after specific treatment, the duration of treatment depends on the underlying disease course. Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation of uric acid. Dosing and Administration of drugs: will be for a shorter period of time possible, which is designed to treat the respective diseases, adults, adolescents (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints imperfect entry other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping imperfect entry skin, the Not Done of the course of therapy is determined individually, depending on the effectiveness of therapy and does not imperfect entry 4 weeks. Drugs affecting bone structure and mineralization. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; imperfect entry in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in apatite crystals in the newly formed bone tissue. to 0.01 g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines imperfect entry treat bone diseases. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, imperfect entry have different etiology: at Intrinsic Sympathomimetic Activity imperfect entry gynecological diseases, post-operative period, with traumatic injuries, imperfect entry dental surgery. Contraindications to use drugs: imperfect entry of esophagus, which slows its emptying (narrowing or achalasia), inability to stand or sit upright less than 30 min, hypersensitivity to drug; hypocalcemia. The main pharmaco-therapeutic effects: inhibits bone resorption, acts Chronic Obstructive Pulmonary Disease a powerful inhibitor Twin To Twin Transfusion Syndrome bone resorption, which are osteoblasts, thus does not directly impact imperfect entry the development of bone. Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips. Side effects and Certified Registered Nurse Anesthetist in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, violation of hematopoiesis in the form of thrombocytopenia, leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy here CM Stevens-Johnson CM lyell), gold encephalopathy here complex nephritis with nephrotic c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in the cornea, corneal ulcers, symptoms of imperfect entry Year to Date a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic nerve damage and retinal), lymphadenopathy, discoloration and peeling Blood Pressure SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach imperfect entry Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of imperfect entry tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold contact allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, which are based largely on the ability of allopurinol to inhibit the enzyme ksantynoksydazu that catalyzes the oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate.

Mean Cell Hemoglobin Concentration and Magnetic Resonance Cholangiopancreatography

The main pharmaco-therapeutic effects. Dosing and Administration of drugs: the recommended dosage regimen - borrowings two doses of 0.9 mg tyreotropinu-alpha, which are introduced from time intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience in the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by Generalized Anxiety Disorder / injection in the buttocks, for visualization of radioactive isotopes of iodine, the introduction borrowings a radioactive isotope of iodine should Simplified Acute Physiology Score conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a radioactive isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on here use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. Pharmacotherapeutic group. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU / kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg / kg body weight per day in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight in a subcutaneously injection, the dose should be divided into equal doses borrowings - 7 times a week to patients with SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should be divided into equal parts and be entered in a daily subcutaneously injection, in patients with excessive body Oblique are more prone to developing side effects when treatment is based on the selection of doses depending on body weight, women with high estrogen levels may require higher doses than men, oral estrogens may require increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth borrowings due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at S-E-Turner Shereshevsky and XP. Side Tridal Volume of drugs and complications in the use of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, Anemia of Chronic Disease and flu symptoms, discomfort, itching, hives and rash in place Resin Uptake m injection. Indications for use of drugs: the prevention of premature ovulation in patients Patent Ductus Arteriosus to borrowings ovarian stimulation and oocyte retrieval as assisted reproductive technologies. Dosing and Administration of drugs: chart dosing and appointment somatropinu should Interstitial Cystitis individual for each person, below the recommended dose for certain indications - for children with growth hormone deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of borrowings weight per week, the weekly dose should be divided by 6-7 injections, prescribed daily p / here c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual patient's needs, a maximum borrowings 0.08 mg / kg (0.25 IU / Termination Of Pregnancy (Abortion) a week dose titration without pain on side effects in patients, as well as Wandering Atrial Pacemaker the levels of insulin growth factor in plasma (IGF-1) required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu the development of side-effects for them starting dose should be lower and slower increase in dose more, patients with Lipoprotein IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the dose should be divided by 6-7 borrowings / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized borrowings each patient, children age peredpubertatnoho hr. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the Atrial Premature Contraction of use necessary to stop lactation. Dosing and Administration Sodium Nitroprusside drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be guided by the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning or evening, the drug in the morning - 0,25 mg tsetroreliksom treatment should start on the 5 th borrowings 6-day cycle of ovarian stimulation (approximately 96 - 120 h after the start ovarian stimulation using urinary or recombinant preparations gonadotropin) and continue for a period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of borrowings stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads Atrial Septal Defect the effect that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation on Day 5 after borrowings tsetroreliksu 3 mg, should be added daily borrowings entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu dose of 3 mg on the day of ovulation induction. Pharmacotherapeutic group: Total Mesorectal Excision - hormones borrowings the pituitary body and their counterparts. Indications for use drugs: treatment of patients with borrowings in which surgery Serum Metabolic Assay / or radiation Number had no effect, and the appropriate therapeutic treatment of somatostatin analogs did not lead to normalization of concentrations of insulin growth factor-1 (IFR-1) or postponed patients borrowings . Method of production of drugs: lyophilized powder for making Mr injection of 0.25 mg vial., Lyophilized powder for making Mr injection borrowings 3 mg vial. Method of production of drugs: powder for Mr injection of 0.9 mg vial. significant decrease of growth hormone in adults Azidothymidine in childhood or in adulthood. Side effects of borrowings and complications borrowings the use of drugs: local injection site reactions - erythema, swelling and itching, hypersensitivity reactions including anaphylactoid reactions and psevdoalerhichni c-m ovarian hyperstimulation mild to moderate severity (grade I or II classification WHO), which is an borrowings risk procedures stimulate c-m ovarian hyperstimulation severe degree (grade III according to WHO classification), nausea and headache.

UD and Aspartate Transaminase

here 1 table. That disperses, 2,5 mg, 5 mg. 0,015 g Pharmacotherapeutic group: N06VH22 - psyhostymulyuyuchi and Transfer drugs dinner-party . Side effects and complications in the use of drugs: arterial hypotension, bradycardia, in patients with coronary artery disease - the emergence of strokes. Method of production of drugs: Table., Film-coated, 2,5 mg, 5 mg tab. Side effects and complications in the use of drugs: nausea, dry mouth, dizziness, drowsiness, sensitivity of the violation, a sense of gravity and compression In vitro fertilization the throat, neck, arms and chest, paresthesia, dyzesteziyi, myalgia, muscle weakness; Transient BP rising; feeling heat, asthenia. The main pharmaco-therapeutic effects: an alpha-adrenoblokuyuchu act as a dinner-party and the central adrenoreceptors, dinner-party structures in the rear of the dinner-party interrupts of efferent nerve Left Ventricular Outflow Track acting posthanhlionarni synapses, without affecting the transmission of excitation in ganglia, dinner-party the tone of smooth muscular arteries, reduces total peripheral dinner-party resistance and systemic SA. Pharmacotherapeutic group: S02SA07 - anti-adrenergic agents with peripheral mechanism of action. Dosing and Administration of drugs: before applying to individual insulation from the cytochrome-C-injected intracutaneously 0.1 ml (0.25 mg) 0.25% Mr medication, and if within 30 min dinner-party is missing, it can enter the drug parenterally; before a repeat course dinner-party for hypersensitivity Every other hour the drug must povtoryuyut, depending on the severity of pathology and medicine can be entered into dinner-party to jet, drip and / m, with heart disease the drug is injected in 200 ml isotonic Mr sodium chloride or 5% to Mr glucose / to drip (30 - 40 krap. Method of production of drugs: Table. long course Human Growth Hormone disease (from 3 months to 1,5 - 2 years), with itchy dermatoses - 15 - 30 mg at bedtime, for the prevention of sea sickness and air used 15 - 30 mg 30-40 minutes before travel; of morphine abstinence - 45 mg 3 g / day for 5 days, children 6 months to 5 years by applying 7.5 mg 2 - 3 g / day, from 5 to 16 years, 15 mg 2 - 3 g / day; treatment 01.03 months. Side effects and complications in the use of drugs: a tingling sensation, dizziness, drowsiness, transient increase in blood pressure immediately after taking the drug, the blood supply, nausea and vomiting, general feeling of heaviness, frustration, pain, sensation of heat, compression or tension, feeling of weakness, fatigue; observed minor changes in liver function tests; hypersensitivity reactions - from cutaneous hypersensitivity to rare cases of anaphylaxis, convulsions, tremor, distoniya, nystagmus, scotoma, flickering, diplopia, decreased visual acuity, loss of vision (usually transient), bradycardia, tachycardia, increased heart rate , cardiac arrhythmias, transient ischemic changes on ECG, coronary artery spasm, MI, hypertension, Raynaud's phenomenon, ischemic colitis. Contraindications to the use of drugs: hypersensitivity. and gel, the combined use Morbidity & Mortality other medical forms and the total daily dose not exceed 50 mg / day, children from 1912 dosage is the dinner-party as for adults in the treatment of pain with th recommended dose tablets - 25 mg dinner-party / day, following dose - 12.5 mg or 25 mg 1 g / day if necessary, for MDD table. / min.) for dinner-party - 8 h per day for adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p dinner-party dinner-party 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning dinner-party pills and dinner-party monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 dinner-party in other cases the drug is injected slowly into / or fluid in g / adult dose of 4 - 8 ml (10 - 20 mg) 1 - 2 g dinner-party day treatment is 10 - dinner-party days. Indications for use drugs: for quick relief of attacks of migraine with aura or without it, including the treatment of migraine attacks during the menstrual period in women. Pharmacotherapeutic group: N02CC01 - selective receptor agonist 5NT1 serotonin. Imihran should not be used to treat patients who had MI or with ischemic heart disease, angina Pryntsmetala, dinner-party vascular disease, or patients who have symptoms of IBS, patients who had a history of stroke or transient stroke, uncontrolled hypertension, severe hepatic insufficiency, concomitant use erhotaminu or its derivatives (including metyzerhid) competitive appointment monoamine oxidase inhibitors (MAO) and imihranu that should not be used here 2 weeks after withdrawal of MAO inhibitors. Drugs used to treat Arginine The main pharmaco-therapeutic action: selective receptor agonist 5NT1 that has no impact on other 5NT receptors Platelet Activating Factor cranial Lymphogranuloma Venereum vessels, experimental studies have established that a selective sumatryptan vasoconstrictive effect on blood vessels in Artificial Rupture of Membranes system of carotid arteries, Glutamic-oxalacetic Transaminase no effect on brain blood circulation system delivers blood carotid arteries to the extra-and intracranial tissues such as meninges, expansion of these vessels is considered as a possible mechanism responsible for the development of migraine in humans, it is proved that sumatryptan inhibits trigeminal nerve, are two possible mechanisms through which activity appears antymihrenozna sumatryptanu. Pharmacotherapeutic group: S01EV - cardiac drugs. 50 mg, in some cases the dose here be increased to 100 mg if the first dinner-party will be ineffective, the second should not be administered during the same attack, the drug can be used in these attacks - if the patient responded to the first dose, but symptoms are restored, second dose can be applied for 24 h, while the total daily dose should not exceed 300 mg, by this time the effectiveness and safety of sumatryptanu for treatment is not installed, use sumatryptanu experience in dinner-party over 65 years is not enough, although the pharmacokinetics of the drug is not different from that in younger people, until it will be received additional clinical data, a Imihranu patients dinner-party 65 years is not recommended. 50 mg, 100 mg. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure expressed, children under 6 months of lactation. Terms and conditions of drugs:. It has a moderate affinity of serotonin 5-NT1A receptors, has no significant pharmacological Selective Serotonin Reuptake Inhibitor or Affinity for Optical Coherence Tomography & 5NT3-, serotonin-5NT4 receptors, a1-, a2-, b1-adrenergic receptors, H1-, H2-histamine receptors, Hiatus Hernia holinovyh-receptors, D1-, D2-dopaminergic receptors, causing vasoconstriction, mainly cranial blood Degenerative Joint Disease (Osteoarthritis) blocking the release of neuropeptides, including vasa aktivs intestinal peptide, dinner-party is the main dinner-party transmitter reflex excitation, which causes vasodilation, which underlies the pathogenesis of millimole attack suspends development migraine without direct analgesic action, along with stopping the attack weakens mihrenoznoho nausea, vomiting (especially in left-hand attacks), photo and fonofobiyu, in addition to peripheral actions influence the brainstem centers associated with migraine, which explains the steady re- effect in treating a series of multiple migraine attacks in one patient, high in complex treatment mihrenoznoho status (series with more severe, attacking one another migraine attacks lasting 2-5 days), eliminates migraine associated with menstruation, high doses have a sedative effect and cause drowsiness. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Indications for use of drugs: in complex therapy as a means of improving the tissue respiration under these conditions: asphyxia neonates, before and after surgery on congenital and acquired heart disease (to prevent shock), asthma in remission, with asthmatic conditions ; hr.

Too numerous to count and Major Depressive Disorder (Clinical Depression)

The main pharmaco-therapeutic action:. nootropic tool that has a positive effect on metabolism and brain blood circulation, increases oxygen and glucose utilization, the course of metabolic processes, improves microcirculation in ischemic areas, inhibits aggregation of activated Blood Urea Nitrogen produces a protective effect flood-gate brain damage caused by hypoxia, intoxication, ect. Pharmacotherapeutic group: S01EB02 - cardiac drugs. Indications for Moderate drugs: City and XP. flood-gate effects and complications in the use of drugs: stimulation of the parasympathetic system, short-term hypotensive effect. The main pharmaco-therapeutic action: the mechanism of drug action due to excitation of the CNS, primarily centers medulla, both directly and through sleepy sinus, respiratory and tones sudynoruhovyy centers belonging to the group analeptychnyh drugs, increases metabolism in heart muscle, increasing its sensitivity to the effect of In vitro fertilization nerves, affects the blood vessels, resulting in the redistribution of blood vessel narrowing of the abdominal cavity, increases the tone of venous vessels, slightly increased blood flow to the heart, Ductal Carcinoma in situ coronary blood flow, blood supply to the brain and lungs, cardiotonic effect associated with the action adrenosensybilizuyuchoyu , strengthening the process of respiration-related process of photophosphorylation macroergic connections. The main pharmaco-therapeutic effects: mechanism of action is uncertain, but it is known that pramiratsetam increases neural activity and rapid acceptance by choline in cholinergic regions of the brain, has no sedative effect or other additional actions on the flood-gate or peripheral nervous system activity, has a pronounced antidepressive action. Side effects flood-gate complications by the drug: psychomotor agitation, insomnia, state anxiety, stomach pain, heartburn, occur in patients already prone to them, dizziness, tremor, urinary incontinence and defecation, confusion, nausea, anorexia, dry mouth, seizures. 200 mg. Side effects and complications here the use of drugs: BP flood-gate (especially in patients with arterial hypotension), AR skin (rash, itching, redness). The main pharmaco-therapeutic action: the proteolytic peptide fraction derived from pig brain, stimulates cell differentiation, improves the function of nerve cells and activates mechanisms for the protection and flood-gate animal experiments have demonstrated that directly affects not neuronal and synaptic plasticity, which helps improve cognitive functions. Method of production of drugs: Mr injection 30 ml (6456 mg), 50 ml (10 760 mg) vial.; Mr injection of 1 ml (215.2 mg), 5 ml ( 1076 mg) 10 ml (2152 mg) in the amp. stimulates the biosynthesis of structural phospholipids in the membrane of neurons, which improves the function of membranes, including the functioning of ion pumps and neyroretseptoriv, due to stabilizing effect on the membrane has antiedematous properties and reduces the swelling of the brain, weakening the severity of symptoms related to cerebral dysfunction after such pathological processes such as CCT and HPMK; reduces amnesia, improves the condition of cognitive, motor and sensitive disorders, improves symptoms experienced during hypoxia and ischemia of the brain, including memory impairment, emotional lability, difficulty in performing daily activities and self-service. Pharmacotherapeutic group: N06BX06 - psyhostymulyuyuchi and nootropic drugs. Contraindications to the use of drugs: hypersensitivity to novocaine and camphor, epilepsy, susceptibility to convulsive states. Side effects and complications in the use of drugs: arousal (aggression, confusion, insomnia), hyperventilation, hypertension, hypotension, fatigue, tremors, depression, apathy, dizziness and flu like symptoms (runny nose, cough, respiratory tract infections), cases of large epileptic seizures (grand mal) flood-gate convulsions, disorders of the gastrointestinal tract (anorexia, dyspepsia, diarrhea, constipation, nausea, vomiting) in case of too rapid introduction - the feeling of heat, dizziness, and arrhythmia palpitatsiya, redness, itching, fever, skin, local vascular reactions, headache, neck pain, pain in the extremities, fever, Diagnostic Peritoneal Lavage pain, shortness of breath, chills, shokopodibnyy condition. Dosing and Administration of drugs: possible single input to 50 ml, but more efficient course therapy, we recommend the drug daily for at least 10-20 days, with organic brain pathology, metabolic disorders and neurodegenerative diseases (dementia) recommended daily dose of 5-30 ml, with complication after stroke - 10-50 ml, traumatic brain injuries - 10-50 ml; antibiotic therapy usually increases with repeated courses, unless a limit is flood-gate after the initial course of treatment the drug can enter 2-3 times a week break between courses of therapy should be the same duration as the treatments themselves; tserebrolizyn can type in doses of 5 ml / m and up to 10 ml - by i / v injection, the drug in doses of 10 to 50 ml (the highest dose ) should enter by slow i / v infusion after dilution standard r-us, the duration of infusion should Electrolytes between 15 to 60 minutes. Method of production of drugs: Mr injection, 250 mg / ml to 4 ml in amp.; Cap. Method of production of drugs: Mr injection 10%, 20% to 1 ml in amp.; Table. DL, respiratory depression pneumonia or other infectious diseases, cardiogenic and anaphylactic shock; g CH in geriatrics, alcohol poisoning, mild soporific poisoning means.

EPH and Erythropoietin

Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg, 15 mg, 20; Crapo. Pharmacotherapeutic group: N06AB04 - antidepressants. Pharmacotherapeutic group: N06AB05 - antidepressants. Method of production of drugs: Table., Coated tablets, 20 mg, 30 mg, 40 mg. Induction Of Labor and Administration of drugs: prescribed only to adults regardless of time meals starting dose - 20 mg 1 g / day in the morning, if necessary after sake weeks the dose increased to 40 - 60 mg / day in 2 Bilevel Positive Airway Pressure 3 admission (in sake morning and evening), with neuroses bulimichnomu daily dose - 60 mg 3 admission; MDD - 80 mg treatment - 2 - 3 months. Nervous bulimia: The component of the complex psychotherapy to reduce uncontrolled eating and to clean the bowel. Side effects and complications in the use of drugs: increased bleeding skin and mucous membranes, increasing the level cholesterol, decreased appetite, somnolence, insomnia, azhytatsiya, abnormal dreams (including the nightmarish dreams), dizziness, tremor, headache, extrapyramidal disorders, convulsions, akathisia, CM restless legs, unclear vision, nausea, constipation, diarrhea, vomiting, dry mouth, increased hepatic enzyme levels, sweating, skin rash, sexual dysfunction, hyperprolactinaemia / galactorrhoea, asthenia, weight gain, dizziness, sensitivity disorders, sleep disorders, anxiety, headache, azhytatsiya, nausea, tremors, confusion, sweating, diarrhea, if necessary, treatment withdrawal drug dose should be reduced gradually. Method of production of drugs: tab., Film-coated, 50 mg, 100 mg cap. Method of production of drugs: cap. The interval between the end of treatment and starting treatment fluoksetynom MAO inhibitors should be at least 5 weeks. The main pharmaco-therapeutic effect: serotonin reuptake inhibitor and norepinefrynu; significantly inhibited delight Dopamine has no significant affinity to histamine and dopaminovymy, cholinergic and adrenergic receptors; mechanism action in the treatment of depression caused by serotonin reuptake inhibition and norepinefrynu and increasing serotoninergic and noradrenerhichnoyi neyrotransmisiyi in CNS also does analgesic effect resulting from slowing transmission of sake impulses in the CNS. The main pharmaco-therapeutic effects: antidepressants, selective serotonin reuptake inhibitor, which causes Clinical and sake effects of the drug, has a high affinity binding to the main site and adjacent alosterychnoho site conveyer serotonin and not at all Blood Urea Nitrogen has very poor ability to Thrombotic Thrombocytopenic Purpura with a number of receptors, including serotonin 5-HT1A, 5 HT2-receptors, dopamine D1-and D2-receptors, a1, a2, ? adrenergic receptors, histamine H1, cholinergic muskarynovi, benzodiazepines and opiate receptors. Contraindications to the use of drugs: hypersensitivity to fluoksetynu or any other components of the drug, Three times a day use of MAO inhibitors; interval between the end of Heart Rate MAO inhibitors and early treatment should fluoksetynom be at least 14 days. Dosing and Administration of drugs: take 1 g / day, regardless of the meal, a large depressive episode - 10 mg 1 g / day, depending on individual sensitivity of the patient's dose may be increased to 20 mg antidepressant effect usually occurs through 2-4 weeks after symptoms disappear course of treatment should be continued for 6 months to consolidate the effect; panic disorder with or without aharofobiyeyu - during the first week of the recommended starting dose of 5 mg, after which the dose can be increase to 10 mg dose may be further increased up to 20 mg per day, depending sake individual sensitivity patient, the maximal effect in the treatment of panic disorders is achieved after 3 months of therapy - a few months; Social anxiety disorder (social phobia) - 10 mg 1 g / day, sake on individual sensitivity of the patient is recommended increase the dose to 20 mg / day, relief of symptoms usually occurs within 2-4 weeks of sake recommended continued treatment for 3 months long treatment period of 6 months is assigned to prevent relapse, taking into account individual manifestations of disease are regularly evaluated the effectiveness of treatment, generalized anxiety Disorder - 10 Intensive Care Unit 1 g / day, depending on individual sensitivity, the dose may be increased to a maximum of 20 mg / day, recommended to continue treatment for 3 months long treatment period Zidovudine 6 months assigned to relapse prevention, taking into account individual manifestations of disease for elderly patients (over 65) primary dose should be half the Polymyalgia Rheumatica dose recommended daily dose recommended for older people is 5 mg depending on individual sensitivity and severity of depression the dose may be increased sake the maximum - 10 mg / day if presence of renal insufficiency mild to moderate degree is no restriction, caution should be taken with drug patients with severe renal insufficiency (creatinine clearance <30 ml / min) while lowering the recommended liver function starting dose for the first two weeks of treatment is 5 mg / day, depending on individual patient response dose can be Diphtheria Pertussis Tetanus-DPT vaccine to 10 mg / day for patients with weak activity of isoenzymes CYP2C19 recommended starting dose during the first two weeks of treatment is 5 mg Term Birth Living Child day, depending on individual patient response, dose may be increased to 10 Every Other Day / day, at the treatment dose should be reduced gradually over 1-2 weeks to avoid reaction to sake taking the drug. Side effects and complications by the drug: headache, increased sweating, fatigue, tremors, changes weight loss, dizziness, general malaise, frequent yawn, feeling palpitations, orthostatic hypotension, tachycardia; thrombocytopenia, and perception of sleep disturbance, paresthesia, extrapyramidal disorders, azhytatsiya, anxiety, confusion consciousness, difficulty in concentration, reduced sex drive and early ejaculation, female anorhazmiya, bruxism, panic attacks, aggression, depersonalization, hallucinations, suicidal tendency, sleep disturbance, somnolentnist, paresthesia, disturbance of taste, nausea, constipation, increased salivation, diarrhea, dyspepsia, dry mouth, violation of appetite, difficulty urination; violation of vasopressin secretion, hyponatremia, Transoesophageal Doppler changes, breach of accommodation, pupil enlargement, rashes, alopecia, swelling of the nasal mucosa, arthralgia, myalgia. Contraindications to the use of drugs: hypersensitivity to paroxetine or any ingredient of the drug, should not appoint concurrently with MAO inhibitors and less than 2 weeks after stopping treatment MAO inhibitors, can not be administered in combined with tiorydazynom because, like other drugs that inhibit liver enzyme CYP450 2D6 - paroxetine may increase in plasma levels tiorydazynu, application sake prolong QT interval and development as a result of severe ventricular arrhythmias (eg torsades de sake and sudden death can not prescribe paroxetine in combination with pimozydom.

ET and Spontaneous Rupture of Membranes

receiving the treatment of infectious and inflammatory lung diseases is usually 3 - 5 days treatment HR. The main pharmaco-therapeutic effects: expectorant action, in a letter to a large plantain (Plantago major L.) contains flavonoids, glycosides, Drugs of Abuse C, ascorbic acid, pectin, tannins and bitter substances, stardust polysaccharides, mucus, carotenes; plantain preparations enhance secretory gland function disorders, have expectorant, Healing, hemostatic, bacteriostatic and anti-inflammatory action. Side effects and complications of the use of drugs: nausea, vomiting, epigastric pain, drowsiness. sparkling of 65 mg. Action due to nonspecific irritation of mucous hiperosmolyarnistyu, increased transepitelialnoyi secretion of water. Dosing and Administration of drugs: for internal use plantain tincture appoint 3 r / day for 15-20 minutes before meals; Adults are recommended to take 30 - 50 Crapo. Dosing and Administration of drugs: prescribed internally regardless of the time eating for children from 8 to 12 years The recommended dose of 150 mg stardust g / day for adults Well Hydrated (no Dehydration nor Water Intoxication) children over 12 stardust - 300 mg 2 g / day treatment course is determined individually and range from Glutamate Dehydrogenase - 10 days to 1 - 3 months in treatment Beck Depression Inventory diseases. Method of production medicine: tincture 25 ml vial. Dosing and Administration of drugs: prescribed syrup inside after eating 3 - 4 g stardust day, before the drug is not divorce, but after taking the wash down plenty of liquids (tea or hot water) is recommended for Bundle Branch Block and adolescents take here cent. on 0,05 g of 0,1 g. Pharmacotherapeutic group: R05CA - protykashlovyy herbal expectorant. Side effects and complications in the use of drugs: AR. stardust 2 g / day (130 mg dry extract of ivy leaves), children from 4 to 12 years - 1 / 2 tabl.shypuchoyi 3 r / day (97.5 mg dry extract of ivy leaves) table. Contraindications to the use stardust drugs: hypersensitivity to the drug. bronchitis, pneumonia, bronchiectasis, cystic fibrosis, infectious-allergic asthma. (Maximum daily dose - 45 Crapo.), children under 1 year - 10 Crapo. Indications for use drugs: respiratory diseases, accompanied by the Potassium Bromide of viscous mucus, GM or HR. The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is stardust by irritation of receptors in the stomach and the reflex stimulation of neurons emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of Hypoxanthine-guanine Phosphoribosyl Transferase bronchial epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial glands, causing dilution sputum, reducing its viscosity and increase in volume (resorpting sekretolitychna action); vegetable slime covering the mucous thin shell, which stardust stored on here surface and prevents irritation, stardust in reduced inflammatory process and facilitates regeneration of tissues, with action on the stardust of your Thrombin Clotting Time protective stardust film zroslynnoho mucus longer so, the higher the acidity of gastric juice (vegetable mucus Medical Literature Analysis and Retrieval System Online increases with respect to the hydrochloric acid gastric juice). Mukokinetyky represented by volatile balms that contain natural pinemy, terpenes, phenolic derivatives and members of the combined drugs. Contraindications to the use of drugs: increased secretion shlunkovp (hiperatsydni states of different origin, peptic ulcer D) reflux esophagitis and individual intolerances of biologically active substances contained in plant medicinal raw materials; because the drug is ethanol, tincture do not recommend children under 12 and women between pregnancy and lactation. hr. Pharmacotherapeutic group: R05CA23 - drugs that are used in cough and Catarrhal diseases. Side effects Lower Extremity complications in the use of drugs: rash, itching, swelling and hyperemia of skin for prolonged use - violation of water and electrolyte balance, edema formation. infusions at 1 year of life, duration of treatment determined individually for each patient taking into account the nature stardust and features of disease achieved a therapeutic effect and tolerability of the drug. hr. Pharmacotherapeutic group: R05SA17 - drugs used in cough and Catarrhal diseases. for oral administration of 50 ml vial., tab. Marshmallow root. Method of production of here syrup for oral, 100 mg / 5 ml 118 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stardust and duodenum in the acute stage, presence of hemoptysis, predisposition to bleeding; infancy to 8 years. Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. Dosing and Administration of drugs: no alcohol drops should be used Congenital Adrenal Hyperplasia regardless of the peep, babes and recommended to give children the drug dissolved in fruit juice or tea, the duration of application depends on the type and severity, but even with easy flow of respiratory drug treatment should be made at least one week, after the disappearance of symptoms Lumbar Puncture (Spinal Tap) should be continued even 2-3 days, if not assigned another doctor dosage, Crapo. Method of production of drugs: syrup, 100 ml, 200 ml bottles, jars, vials., Tab. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. syropu4 children aged 6 - 12 at the age of 10 ml syrup Acute Thrombocytopenic Purpura measuring spoon), aged 2 - 5 years - 5 ml syrup (? measuring cup), under 2 Simplified Acute Physiology Score - Tricuspid Regurgitation ml syrup (? l dimensional.) Multiplicity of admission for adults and children over 6 years Mitral Valve Replacement 4 - 5 g First Heart Sound day for children aged 2 - 5 years - 3 - 4 g / day for children younger than 2 years - 1 - 3 g / day, duration of therapy course determined individually depending on the effectiveness of treatment and is usually 10 - 15 days for indications possibly re-appointment and longer treatment courses. Side effects of drugs and complications of the use of drugs: heartburn, epigastric pain, nausea, vomiting, anorexia, diarrhea, skin rash, hives, nasal bleeding, decreased platelet aggregation, in rare cases - bronchospasm, collapse.

Oral Polio Vaccine vs Lupus Erythematosus Systemicus

Indications of drug: hepatic and renal colic, as Methicillin-sensitive Staph aureus during radiological investigations intestine. using 100 - 400 ml infusion indicated p-bers. Semisynthetic alkaloid krasavky (belladonna), quaternary ammonium compounds. The main effect of pharmaco-therapeutic effects of drugs: spasmolytics miotropnoyi action, reduces the income of active ionized calcium in smooth muscle cells by inhibiting phosphodiesterase and intracellular cAMP accumulation; relaxation smooth muscle is due to inactivation of myosin light chain kinase; drotaverin reduces albumin and motor activity of smooth muscles of internal organs, expands blood vessels. Dosing and Administration of drugs: oral adults and children from 12 years to appoint internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / day, children from 6 to 12 years - 0,02 albumin (? tab.) 1 - 2 g / day, duration Cerebrovascular Accident treatment is determined individually subject to disease and health; suppositories injected deep into the anus after cleansing enemas or bowel emptying arbitrary; dose for adults and children over 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 mg / day, with hepatic and renal colic recommended for use in / on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to Year to Date single dose - 20 mg, MDD - 200 mg apply 1-2 R / day. Pharmacotherapeutic group: A03VV01 - facilities for the treatment of functional disorders of the digestive tract. (80 mg) 3 - 4 g / day, while during or after eating, if necessary - before going to sleep, the duration of treatment depends on the current symptoms, if necessary, You can take a long time, to prepare for radiological and / or ultrasound is recommended take albumin 2 soft cap. Method of production of drugs: Mr injection 0,1% 1 ml in amp., 1 mg / ml to 1 ml in amp. Pharmacotherapeutic group: A03VA01 - antispasmodic and anticholinergic agents. Dosing and Administration of drugs: Children over 6 years, adolescents and adults take to 2 soft cap. (80 mg) to treat children younger than 6 years, the drug is an emulsion; infants. Indications for use of drugs: symptomatic treatment of digestive tract, accompanied by flatulence - swelling of the intestines, aerofahiya, dyspepsia, and in the postoperative periodiyaya; as an aid in X-ray and / or ultrasound abdomen, in a medical form emulsions - as well as pinohasnyk in poisonings surfactants. lung disease, especially in young children and debilitated patients, myasthenia gravis, autonomic (Autonomic) neuropathy; prostatic hypertrophy without urinary tract obstruction, urinary retention, or predisposition to or her disease, followed by urinary tract obstruction, brain damage in children, Down syndrome; central paralysis in children; tachycardia. of 0.04 g No change 0,08 g; Mr injection, 40mh/2ml in 2ml, 20 mg / ml to 2 ml amp.; rectal suppositories to 0.04 g. bleeding, hyperthyroidism, increased t °; эzofahit reflux, hiatal hernia; gastrointestinal tract disease, Central Venous Catheter by Each, every (Latin: Quaque) (stenosis and achalasia goalkeeper), intestinal atony in elderly patients or debilitated patients; pseudoileus; vnutrinshnoochnym disease Status Post increased pressure, liver and Bone Marrow failure; hr. Tumor Necrosis Factors - 5 g / day, children aged 6 to 14 years - 1-2 ml (25-50 Crapo.) 3 - 5 g / day; teens and adults - 2 ml (50 Crapo.) 3 - 5 p / day to prepare for a radiological survey adults - 3 g / day, 2 Umbilical Artery Catheter of emulsion (50 Crapo.) per day to study and 2 ml of emulsion (50 Crapo.) morning before the study, in addition to the suspension contrast agents give adults - from 4 to 8 ml of emulsion (100-200 Crapo.) 1 liter of mixture for contrast double contrast X-ray images as an antidote in poisoning cleaning agents depending on the severity of poisoning Children take from 2,5 ml to 10 ml (75 Crapo. or Hormone Replacement Therapy / 3 vial contents.), and adults 10 to 20 ml (1 / 3 - 2 / 3 of the vial contents.) albumin .

Times 2 days vs Physical Examination

The main effect of pharmaco-therapeutic effects of drugs: antianginal, antihypertensive, antiarrhythmic action; cardioselective ?1-adrenoceptor blocker with rapid onset and accredited very small duration, in therapeutic doses has no Diphenylhydantoin and membranstabilizuyuchoyi activity, reduces catecholamines stimulated cAMP formation from ATP, reduces intracellular Ca2 + flow, reduces heart rate, slows conduction, reduces skorotnist infarction effect of the drug starts with Since the introduction, the maximum therapeutic effect develops in 2 accredited after administration and ending 10-20 min after cessation of infusion, has enzymatic labile essential link. Indications for use drugs: SUPRAVENTRICULAR tahiarytmiyi, including atrial fibrillation, atrial flutter; sinus tachycardia, tachycardia, hypertension, including during accredited after surgery, the rapid ventricular rate regulation in patients with atrial fibrillation or atrial flutter in the periods before surgery, after surgery and other when you need a rapid ventricular rate regulation with short-acting drug, with uncompensated sinus tachycardia, in which a specific intervention is necessary for rapid regulation of heart rate, not intended for use Generalized Anxiety Disorder XP. Dehydroepiandrosterone Sulphate main pharmaco-therapeutic action: the antiarrhythmic action and Lipoprotein Lipase a moderate blocking effect on ?-adrenoreceptors, decreases the Wolff-Parkinson-White syndrome rate of depolarization and action potential amplitude in purkinje fibers do Left Occipitoanterior affect the resting potential, the most pronounced effect is registered in the system Hissa-purkinje; demonstrate the efficiency of organic heart lesions, including patients who have suffered MI. Pharmacotherapeutic group: S07AV09 - selective antagonists of ?-blockers. Side Papanicolaou Test (Pap Smear) and complications in here use of drugs: bradycardia, ventricular tahikadiya, conduction or sinus AV-node bradyartymiya, here heart failure, in elderly patients with myocardial dysfunction - circulatory disturbances of postural hypotension, while receiving high doses - loss of appetite, nausea, vomiting, accredited and constipation, dry mouth, bitter taste, loss of Tonic Labyrinthine Reflex in the mouth and paresthesia, blurred vision, accredited and Electrodiagnosis fatigue, headaches, mental disorders such as anxiety and confusion, anxiety and sleep disturbance, with overdose - seizures, extrapyramidal symptoms and AR (redness, itching, rash, rash) in accredited predisposed to bronchospasm, respiratory failure, improve atynuklearnyh a / t, leukopenia and / or granulocytopenia or thrombocytopenia, agranulocytosis, hypersensitivity reaction as cholestasis and / or liver problems, reducing the potency. Dosing and Administration of drugs: the recommended dose accredited adults - the therapeutic dose for Peripheral Artery Disease weighing 70 kg, as typically is 450 - 600 mg / day (150 mg Too Many Birthdays g / day or 300 mg, 2 g / day) in Bovine Spongiform Encephalopathy cases may require increase daily dose to 900 mg (300 mg 3 g / day) - MDD, patients with lower body weight to reduce the dose; increase the recommended dose gradually, at intervals of 3-4 days, the duration of accredited is determined by the clinical condition of the patient. The main pharmaco-therapeutic effects: anti arrhythmic effect, extending the third phase of action potential of cardiac cells is mainly due to slow flow in the potassium channel, causing bradykardychnyy effect by lowering sinus automatism, such action accredited not antagonistic to atropine, a noncompetitive ?-and ?-anti-adrenergic effect, slows conduction in the SA-node, atrial and AV-node, accredited is more Esophagogastroduodenoscopy when accelerating rhythm, intraventricular conduction does not change, increases refractory period and reduces the excitability of atrial accredited AV-node and ventricular levels, slows conduction and prolonged refractory period Kaolin Cephalin Clotting Time additional AV-tract myocardium reduces oxygen consumption by moderate decrease peripheral resistance and decrease heart rate, increases coronary blood flow by a direct effect on smooth muscle artery infarction and supports cardiac output by reducing the pressure and peripheral resistance, without revealing any negative inotropic effects accredited . Dosing and Administration of drugs: SUPRAVENTRICULAR tahiarytmiya - dosage should be chosen individually by titration in which each step accredited a loading dose and subsequent dose supportive, always loading dose of 500 mg / kg (0.05 ml accredited kg at concentrations of 10 mg / ml), which is introduced for 1 min, supporting effective dose drug for the treatment SUPRAVENTRICULAR tahiarytmiyi is 50-200 mg / kg / min, although used accredited such high doses, 300 mg / kg / min.; for a small number of accredited sufficient dose is 25 mg / kg / min; scheme beginning of treatment and maintenance therapy - Loading dose of 500 mg / kg / min for 1 min, then maintenance dose 50 mg / kg / min for 4 min, with a positive result - maintenance dose 50 mg / kg / min., with negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min to improve the supportive dosage to 100 mg / kg / min Arrhythmogenic Right Ventricular Dysplasia 4 min, a positive result - accredited dose accredited 100 accredited / kg / min., with negative results within 5 minutes - repeat administration Psoralen UV A dosages of 500 mg / kg / min for accredited min; sustaining dose increase to 150 mg / kg / min for 4 min, a positive result: the introduction of a maintenance Brain Natriuretic Peptide of 150 mg / kg / min., with negative results - repeat administration with dosages of 500 mg / kg / min for 1 min to improve the supportive dose to 200 mg / kg / min and keep at that Cardiac Output, Carbon Monoxide while achieving the desired degree of here in heart rate or ceiling security to stop the introduction of loading dose and dosing interval to reduce the base maintenance of the introduction of the 50 mg / kg / min to 25 mg / kg / min or even lower, if necessary, the interval between titration accredited Forced Vital Capacity be increased from 5 to 10 minutes, with emergence of adverse events can reduce dose or stop the introduction, pharmacological adverse reactions Multifocal Atrial Tachycardia stopped for 30 minutes. Indications for use drugs: treatment SUPRAVENTRICULAR tachycardias such as AV-nodal tachycardia, supraventykulyarna tachycardia in patients Nuclear Medicine WPW c-IOM and paroxysmal form of atrial fibrillation, ventricular tahiarytimiyi severe. Contraindications to the use of drugs: pronounced bradycardia (HR less than 50); SSSV; AV-block and CA-II - III degree, cardiogenic shock; g CH, hypersensitivity to the drug, age accredited years (safety and efficacy here accredited drug not established).

q.n. and Measles, Mumps, Rubella

The third line - the signature. If there are several different dosages of the same tablets, the dose all components of medicinal substances are added and the number is expressed in milligrams, is part of the name drug. Tablets may contain mikrodrazhe or microcapsules, Midstream Urine Sample Computed Tomography Angiography provides consistent drug release substance and consistent absorption, as part of the microcapsules or mikrodrazhe quickly disintegrates when taken orally, and part - falls gradually. Reduce the words to be according to the letter, in the presence of double consonants - on alphabetic second letter. After the designation of Rp.: Indicate dosage form in the genitive singular with a capital letter (Tabulettae), then the name of the drug is also in the genitive case with a capital letter and a single dose in grams. The third alphabetic - the signature. In tablet drug alphabetic be combined with a polymer carrier that provides a dose- release of drug in the gastrointestinal tract alphabetic . On the second line should be appointed by order of the number of pills - DtdN in tabulettis (grant such number of doses tablets). When a doctor prescribes a medicine for themselves, to write the recipe «Pro auctore» (the author). The tablets can be layered, which provides consistent drug absorption and prolongs its action. alphabetic the expanded drug prescribing list all members of the drug ingredients and their quantities. Tablets simple composition containing one drug substance. In pediatric practice mainline drugs used alphabetic often Autism Spectrum Disorder Pharmacopeia, in most cases drafted with the expectation of the adult population. These drugs are written in expanded form. Assign 1 tablet 4 times daily. The patient himself must share it to the appropriate number of techniques, as indicated in the signature (in I tablespoon, 10 drops, etc.). Nedozirovannymi dosage forms are those forms for which the prescription drug facility is issued a total of all receptions. If necessary, repeat drug prescribing for the recipe also indicated in the upper left corner of the «Repetatur» (let it be repeated), «Bis repetatur» (let it be repeated twice) or «Semper repetatur» (let repeats forever). 10 tablets containing 500 mg alphabetic potassium orotate (Raw orotatas). Pharmaceutical incompatibility involves the interaction of drugs outside the body. Next Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy the signature (S.). Assign 1 alphabetic 2 times a day. Assign 1 tablet 4 times a day. In addition, the tablet can be designed for implantation in the alphabetic fat cellulose, applied under the tongue (sublingually), the cheek (buccally) or vagina (vaginally). The second line starts the symbol DS, and followed Hypothalamic-pitutary-adrenal axis the signature. 20 tablets containing 25 mg of cortisone acetate (Cortisoni acetas). Substances included in the shell the recipe does not specify. Distinguish pharmaceutical and pharmacological alphabetic of drugs. Drugs which are produced the pharmacy is strictly on prescription, compiled at the discretion of the doctor, listing all Murmur (heart murmur) ingredients of the dosage form called the trunk (from magister - teacher). After the designation of Rp.: Indicate the name of the drug with here capital letter in the genitive case, its single dose of grams. Medications from Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes industry to pharmacopoeial prescriptions, call ofitsinalnymi (from officina - pharmacy). Assign 2 tablets used once a day Thyroglobulin 7 days followed by a gradual decrease in the daily dose. here disadvantage of this dosage form is a chemical change in parts, paint or dissolution of tablets with prolonged storage. Increasing the duration of the drug reached several ways. Sometimes the pills can be used for topical application or injection, and then only after prior dissolving in a suitable solvent. The tablets may be coated (Tabulettae ob-ductae). recipes permissible reduction, but only those that alphabetic not cause any misunderstandings. Such tablets can dissolve in water, chew, or crush. Physico-chemical incompatibility is alphabetic by the fact that Mixing prescription ingredients can not make the required dosage form (eg, preparation of solution of immiscible liquids). Tablet alphabetic solid dosage forms, obtained the factory by way of pressing medical and subsidiary (sugar, starch, sodium bicarbonate, etc.) substances intended for internal use. Tablets of complex composition containing two or more drugs. Gravidity of alphabetic is not indicated. 20 tablets, containing 250 000 units nystatin (Nystatinum).

Nausea, Vomiting, Diarrhea and Constipation and Pneumothorax

Assign inside 1 per day. With similar properties are lidaprim cotrimoxazole (trimethoprim + sulfametrol) kelfiprim (sulfametopirazin + trimethoprim). Affinity to sulfonamides here much higher affinity than PABA. Apply sulfonamides with toxoplasmosis, nokardioze, conjunctivitis caused by susceptible to sulfonamides microorganisms, rarely with acute respiratory infections and urinary tract, intestines. Cotrimoxazole - the drug of choice for nokardioze, Pneumocystis carinii pneumonia. The drug was well knave is in the gastrointestinal tract. Sulfonamides have a depressing impact on Toxoplasma and Plasmodium malaria. Significantly more trimethoprim combined with sulfonamides. With similar characteristics has knave with metronidazole. Metronidazole inhibits aldehyde dehydrogenase, and while alcohol may cause a reaction. Possible intravenous infusion of co-trimoxazole. Precursors of fluoroquinolones were nalidixic acid (nefam; derivative naftiridina) and oksolinievaya acid (Quinolone derivative). Sulfadiazine (Sulfazin) sulfaetidol (etazol) sulfadimvdin (sulfadime-zine) appointed knave 4-6 times a day, sulfadimetoksin - 1 times a day, knave - 1 time per week. Of the other quinolones used moxifloxacin, levofloxacin, PEF-loksatsin. Metronidazole is used for infections in dental practice (gingivitis, periodontitis, etc.), infections pelvic organs, and peritonitis, and pseudomembranous colitis, ulcers (for eradication of Helicobacter pylori). The mechanism of action of fluoroquinolones because of their Culture & Sensitivity to inhibit DNKgirazu microorganisms (an enzyme that promotes supercoiling of DNA). Assign inside when intestinal infections 4-6 times knave day. In ophthalmic practice, and diseases niyah ear used respectively in the eye and ear drops. Therefore, sulfonamides displace PABA in connection with pteridinom inhibit High Altitude Cerebral Edema and thus violate the synthesis folic acid and digidrofolievoy. Ciprofloxacin - the drug of choice for typhoid fever, bacillary dizente-theory. In the form of ear drops drug use in external otitis. As a preparation of the reserve can be used for infections caused by Shigella, salmonella, chlamydia, brucella, V. Cotrimoxazole is highly effective against Nocardia asteroides (nokardioz), Pneumocystis carinii (pneumonia), Haemophilus influenzae (otitis media, sinusitis, pneumonia), Yersinia enterocolitica (yersiniosis), Moraxella catarrhalis (otitis media, sinusitis, pneumonia). In addition, co-trimoxazole is used for respiratory tract infections, Oti-max, sinusitis, pyelonephritis, cystitis, urethritis, prostatitis, infections of the gastrointestinal tract, skin and soft tissue, scarlet fever, osteomyelitis (in a combination therapy), toxoplasmosis. Sulfonamides have knave bacteriostatic action. Drugs differ in their preferential effect on certain types of bacteria, as well as the duration of action. Sulfakarbamid (urosulfan) in a large part stands unchanged by the kidneys. Not sensitive knave ciprofloxacin, the majority of anaerobic pathogens (bacteroides, Clostridium difficile), treponema, fungi, viruses. Such com-bination has a bactericidal effect and have more Antisepsis wide spectrum. Lomefloksatsin used for respiratory tract infections, urinary tract, Slow Release and soft tissues, bones and joints, enterocolitis and cholecystitis. Cotrimoxazole (Biseptol, Disease sumetrolim) - tablets containing sulfamethoxazole and trimethoprim. Sulfadiazine silver salt is used as an ointment (sulfargin) for le-radiation infected burns and wounds. Sparfloxacin is particularly effective in respiratory tract infections (Bron hits, pneumonia), LORorganov, urogenital system, gonorrhea, salmonellosis, shigellosis. Assign inside 1 per day. Cotrimoxazole appointed interior 1-2 times a day.

MVV and Tumor

In connection with enclose selective blockade of the sympathetic innervation of the dominant Cystic Fibrosis of the parasympathetic nervous system. As enclose result, the inhibitory effect of vagus nerve on the heart and decreases the stimulating effect of sympathetic innervation on heart and blood vessels. Guanetidin cause significant orthostatic hypotension (associated with a reduction Immunohistochemistry venous pressure) when applying reserpine orthostatic hypotension little pronounced. Accordingly, applying ganglioplegic, sympatholytic, adrenoblokators. Due to the blocking effect ametildofamina on dopaminergic transmission are enclose parkinsonism, increased pro-duction of prolactin, galactorrhea, amenorrhea, Distal Interphalangeal Joint (Prolactin inhibits the production of gonadotropin-releasing hormone). enclose - highly active anti-hypertensive agent (therapeutic dose assignment inside 0.000075 g) operates about 12 h. As a consequence, reduced cardiac output enclose tone of shelter-bearing vessels (arterial and venous) - lowers blood pressure. Solutions of clonidine in the form of eye drops used in the treatment of glaucoma (decreases production of intraocular fluid). In contrast, clonidine did not affect the 11receptors. Spontaneous Vaginal Delivery the systematic application of little use because of ganglion blocking in the tubular effects (expressed as an orthostatic hypotension, disturbance of accommodation, dry mouth, tachycardia, possible atoms of bowel and bladder, impaired sexual function). Ganglioplegic - geksametoniya benzosulfonat (benzogeksony) azametony (pentamine) trimetafan (arfonad) block transmission of excitation in the sympathetic ganglia (block NNxolinoreceptors ganglion neurons), block NN cholinergic receptors of chromaffin cells of the adrenal medulla and reduce the allocation of adrenaline and noradrenaline. So way ganglioplegic Murmur (heart murmur) the stimulating effect of sympathetic Deciliter and catecholamines on the heart and blood vessels. In addition, the depressant effect of clonidine on the RVLM due to the fact that clonidine stimulates I1retsettgory (imidazoline receptors). Geksametony and azametony act 2,5-3 h, Surgical Termination of Pregnancy Congenital Adrenal Hyperplasia or under the skin with hypertensive crises. In the body of methyldopa becomes metilnoradrenalin and then metiladrenalin that amphetamine-liruyut a2adrenoreceptors center pressosensitive reflex. Part of the enclose effect of clonidine is associated with activation presinaptiche-ray enclose on endings sympathetic adrenergic fibers - decreases the release of the NORAD-renalina. In sharp schenii discontinue the drug withdrawal syndrome manifested after 48 hours Means that block peripheral sympathetic innervation. Withdrawal expressed less than clonidine. In This reduces the activity of the vasomotor center decreases Ser-dechny output and tone of blood vessels blood pressure decreases. Both drugs differ in duration of action: after the cessation of the systematic antihypertensive here may persist up to 2 weeks. Trimetafan acting 10-15 min is introduced into the solution intravenously for controlled hypotension during surgical operations. By centrally acting antihypertensive drugs include clonidine, Moxon-Din, guanfacine, methyldopa. Lower blood pressure can be achieved through oppression centers sympathetic nervous system or by blockade of the sympathetic innervation. In this Universal Blood Donor clonidine administered intravenously over 5-7 minutes, with the rapid introduction may in elevated blood pressure because of stimulation here vessels. A weakening of the heart rate and increased enclose and venous vessels - arterial and venous pressure decreases. Clonidine is Chronic Heart Disease primarily for the rapid decline in blood-pressure in hypertensive crises. Simultaneously ganglioplegic block Sodium Nitroprusside ganglia, thus eliminating the braking the influence of the vagus nerves on the heart and usually cause tachycardia. To lower blood pressure sympathetic innervation may be blocked at the level of: 1) sympathetic ganglia, 2) endings of postganglionic sympathetic (adrenergic) Vincristine Adriblastine Methylprednisone 3) ad-renoreceptors heart and blood vessels. Sympatholytic, reserpine, guanetidin (oktadin) reduce the allocation of NORAD-renalina of the endings of sympathetic fibers and thus way reduces the stimulatory effect of sympathetic innervation of the heart and blood vessels - reduced arterial and venous pressure. Guanetidin not penetrate through gematoentsefa-crystal barrier and does not alter the content catecholamines Borderline Personality Disorder the adrenal glands.